CAS: 95896-78-9 - 2-Amino-3,4,8-trimethyl-3H-imidazo [4,5-f] Quinoxaline
Formula:C12H13N5
InChI:InChI=1S/C12H13N5/c1-6-4-8-9(15-7(2)5-14-8)10-11(6)17(3)12(13)16-10/h4-5H,1-3H3,(H2,13,16)
InChI key:InChIKey=LAZSIJHHPMHKQI-UHFFFAOYSA-N
SMILES:N1=CC(=NC2=C1C=C(C3=C2N=C(N)N3C)C)C
- Synonyms:
- 2-Amino-3,4,8-trimethylimidazo(4,5-f)quinoxaline
- 3,4,8-Trimethyl-3H-imidazo(4,5-f)quinoxalin-2-amine
- 3,4,8-Trimethylimidazo(4,5-f)quinoxalin-2-amine
- 3H-Imidazo(4,5-f)quinoxalin-2-amine, 3,4,8-trimethyl-
- 4,8-DiMeIQx
- 4,8-Dimethyl IQX
- Brn 5344583
- Ccris 6408
- Di-meIQX
- Dimethyl-IQX
- See more synonyms
2-AMINO-3,4,8-TRIMETHYLIMIDAZO[4,5-F]QUINOXALINE
CAS:95896-78-9
Formula:
C12H13N5
Color and Shape:
Solid
Molecular weight:
227.2651
Ref: IN-DA005WK0
Undefined size | To inquire |
Estimated delivery in United States, on Friday 29 Nov 2024
2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline
CAS:95896-78-9
Formula:
C12H13N5
Purity:
98% (Typical Value in Batch COA)
Color and Shape:
yellowish green solid
Molecular weight:
227.27g/mol
Ref: 54-OR3100T
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline
CAS:95896-78-9
Applications A mutagenic/carcinogenic heterocyclic amine formation in fried beef steak. References Environmental Health Perspectives, 67, …
Formula:
C12H13N5
Color and Shape:
Yellow To Dark Beige
Molecular weight:
227.27
Ref: TR-A631000
5mg | 220.00 € | ||
10mg | 347.00 € | ||
25mg | 800.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline
CAS:95896-78-9
2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline is a metabolite of the heterocyclic amine 2-amino-1-methyl-6-(phenylamino)pyridine (PhIP) and is a potential carcinogen. …
Formula:
C12H13N5
Purity:
Min. 95 Area-%
Color and Shape:
Powder
Molecular weight:
227.27 g/mol
Ref: 3D-FA17489
1mg | 248.00 € | ||
2mg | 364.00 € | ||
5mg | 517.00 € | ||
10mg | 740.00 € | ||
25mg | 1,276.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025